Read the Latest News

New Report on Temporomandibular Disorders: Priorities for Research and Care

Over a year and half ago, the National Academy of Medicine (NAM) began the most comprehensive study ever undertaken on Temporomandibular Disorders (TMD). The study assessed the current state of TMD research, education and training, the safety and efficacy of clinical treatments, and associated burden and costs.

Statement by NIDCR Acting Director on the National Academies of Sciences, Engineering, and Medicine Report on Temporomandibular Joint Disorders

I am pleased to announce the release of the National Academies of Sciences, Engineering, and Medicine (NASEM) report, Temporomandibular Disorders: Priorities for Research and Care. As underscored by the comprehensive report, temporomandibular joint disorders (TMJDs) are a diverse and still poorly understood set of complex, painful conditions affecting the jaw muscles and tissues, temporomandibular joints, and associated nerves. Clearly, there is much more to be understood, and these conditions continue to confound medical and dental health care providers and researchers.

Have you seen the film Dark Waters?

The Film. Dark Waters is about attorney Robert Billott's real-life 20 year legal battle against DuPont chemical for releasing toxic waste - perfluorooctanoic acid, or PFOA - into Parkersburg, West Virginia's water supply, with devastating health effects on the townspeople and livestock. PFOA, also known as C8, is a man-made chemical. It is used in the process of making Teflon and similar chemicals known as fluorotelomers.

Online TMD Diet Diary Research Project

Online TMD Diet Diary Research Project The TMJ Association received the following request from Professor Justin Durham and his research team at Newcastle University. We encourage TMJ patients to participate in this project as it is an under researched

Drug Induced Bruxism

The authors of this article state that orofacial movement disorders (bruxism) are treated typically by dental professionals and not by those specialists (neurologists) researching and treating the other movement disorders (Parkinson's disease, Huntington's disease, tremors, etc.). Again, this is more evidence of the complexity of TMD and the need for multidisciplinary research and treatment in TMD.

TMJ Disorders & Botox

  • Jan 27, 2017

The Wealthy Dentist, a dental marketing company, recently published results from a poll surveying members, “What particular dental treatments do you want to push to your patients?”  Survey results indicated TMJ disorders were ‘pushed’ by half of dentists responding and was included in their marketing efforts. A Minnesota dentist who participated in the poll stated:

"… I do provide Botox to help with TMD issues, as well as cosmetic, which is a recent service we provide.  Botox and fillers are helping me support my practice while I am at this point in time still a Delta Dental provider and is not profitable...  MN still has a provider tax that is on gross receipts and donated dental services; again, the Botox and fillers helps subsidize the practice to practice.  I love providing this service too.  No stress, reversible, patients love it and ask for it and pay in full the day of service. MDs are using these services 'Cross subsidizing' as well.  This is all something to ponder on."

According to The National Institutes of Health brochure on TMJ disorders  BotoxTM (botulinum toxin type A) is a drug made from the same bacteria that causes food poisoning.  Used in small doses, BotoxTM injections can actually help alleviate some health problems. The Food and Drug Administration (FDA) has approved BotoxTM for the treatment of certain eye muscle disorders, cervical dystonia (neck muscle spasms), and limited cosmetic use.  BotoxTM has not been approved by the FDA for use in TMJ disorders. Research is under way to learn how BotoxTM specifically affects jaw muscles and their nerves. The findings will help determine if this drug may be useful in treating TMJ disorders.

The Cochrane Collaboration, an international and highly regarded agency conducting scientific reviews of clinical interventions of products used in the diagnosis, prevention or treatment of diseases, completed a study of the use of botulinum toxin type A in masseter muscle hypertrophyThe reviewers concluded that there simply were not enough high quality studies to properly evaluate the toxin’s effectiveness nor its potential harms, and called for future research sufficient to provide evidence for people to make informed decisions about its use.

Just the facts.

TMJ Disorders

Comments:

Login or Register to add Comment